Download Files:
Products Details
Product Description
– (Rac)-ErSO-DFP is a derivative of ErSO-DFP and a selective small molecule Erα biomodulator. (Rac)-ErSO-DFP againsts ERα+ breast cancer (including resistant tumors) by hyperactiving the Erα-dependent a-UPR (extracted from patent WO2022087234A1)[1].
Web ID
– HY-144070A
Shipping
– Room temperature
Applications
– Cancer-programmed cell death
Molecular Formula
– C20H17F5N2O2
References
– [1]Hergenrother, et al. Enzyme-activating compounds and compositions. Patent WO2022087234A1.
CAS Number
– 2768139-73-5
Molecular Weight
– 412.35
SMILES
– O=C1NC2=C(C=CC=C2C1(N3CCC(F)(CC3)F)C4=CC=C(C=C4)O)C(F)(F)F
Clinical Information
– No Development Reported
Research Area
– Cancer
Solubility
– 10 mM in DMSO
Target
– Estrogen Receptor/ERR
Pathway
– Vitamin D Related/Nuclear Receptor
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
